The interferon-stimulated gene TRIM22 : A double-edged sword in HIV-1 infection
- 1 April 2018
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 40, 40-47
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferonsScientific Reports, 2012
- Towards an HIV cure: a global scientific strategyNature Reviews Immunology, 2012
- HIV DNA IntegrationCold Spring Harbor Perspectives in Medicine, 2012
- TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat ElementsJournal of Virology, 2011
- Association of TRIM22 with the Type 1 Interferon Response and Viral Control during Primary HIV-1 InfectionJournal of Virology, 2011
- c-Myc and Sp1 Contribute to Proviral Latency by Recruiting Histone Deacetylase 1 to the Human Immunodeficiency Virus Type 1 PromoterJournal of Virology, 2007
- A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1Science, 2007
- Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencingThe EMBO Journal, 2007
- The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeysNature, 2004
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002